This proposal is for the 5th year through the 9th year of the Resource Facility for Kinetic Analysis (RFKA) at the University of Washington. Kinetic analysis and integrated systems modeling have contributed substantially to our understanding of physiology and pathophysiology of metabolic systems in humans and animals. In recent years, many experimental biologists have become aware of the usefulness of these techniques in their research. With this has come the recognition that the discipline of kinetic modeling requires its own expertise. RFKA provides that expertise as a part of fulfilling its goals which are: 1) the development and application of modeling technology to biomedical problems, 2) the enhancement and maintenance of computer based methodologies for kinetic modeling with major emphasis on the SAAM (Simulation, Analysis and Modeling) programs, 3) the provision of service to the biomedical community via consultation in the use of modeling in the analysis of kinetic data, 4) the education and training of individuals in the use of modeling technology in biomedical research, and 5) the dissemination of our technology, expertise and accomplishments. Modeling and experimentation are both integral parts of the testing of hypotheses. Modeling is needed in the planning as well as in the analysis of experiments, and provides more focused and efficient experimental designs. By enhancing the contribution to modeling, RFKA supports this concept of an integrated experimental design. RFKA is distributed over three sites at three major universities; the Administrative Core of RFKA is located at the University of Washington. All sites take part in the functions that define a Resource, but each contributes a unique expertise in at least one area. The geographical distribution and diversity of interest in each has, over the first 2 1/2 years, facilitated a growth in collaborative and service activities.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
2P41RR002176-05
Application #
3104048
Study Section
Special Emphasis Panel (SSS (C))
Project Start
1986-09-30
Project End
1993-11-30
Budget Start
1990-12-18
Budget End
1991-11-30
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wolfe, B M; Barrett, P H; Laurier, L et al. (2000) Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women. J Lipid Res 41:368-75
Vicini, P; Zachwieja, J J; Yarasheski, K E et al. (1999) Glucose production during an IVGTT by deconvolution: validation with the tracer-to-tracee clamp technique. Am J Physiol 276:E285-94
Parhofer, K G; Barrett, P H; Schwandt, P (1999) Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parameters. Atherosclerosis 144:159-66
Vicini, P; Caumo, A; Cobelli, C (1999) Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation. IEEE Trans Biomed Eng 46:130-7
Burnett, J R; Wilcox, L J; Telford, D E et al. (1999) The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Endocrinology 140:5293-302
Vicini, P; Cobelli, C (1999) A priori identifiability of distributed models of blood-tissue exchange. Ann Biomed Eng 27:200-7
Cobelli, C; Caumo, A; Omenetto, M (1999) Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol 277:E481-8
Heatherington, A C; Vicini, P; Golde, H (1998) A pharmacokinetic/pharmacodynamic comparison of SAAM II and PC/WinNonlin modeling software. J Pharm Sci 87:1255-63
Colvin, P; Moriguchi, E; Barrett, H et al. (1998) Production rate determines plasma concentration of large high density lipoprotein in non-human primates. J Lipid Res 39:2076-85
Lamarche, B; Uffelman, K D; Steiner, G et al. (1998) Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model. J Lipid Res 39:1162-72

Showing the most recent 10 out of 69 publications